CLINICAL_TRIALS
research
· 2025-10-07
Clinical Trial Update: Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers. [Phase 4]
Summary
A Phase 4 trial sponsored by Royal Biologics is evaluating Amnio-Maxx for healing diabetic foot ulcers; the study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Royal Biologics | Conditions: Diabetic Foot Ulcer (DFU), Amnio-Maxx | Phase 4 | Status: RECRUITING